About X-ray Crystallography
X-ray crystallography is mainly used for defining the arrangement of particles inside crystals. The X-rays diffracted through a crystal are measured by the crystallographer for determining the electron density of the crystal and providing a 3D image of the same. X-ray crystallography also determines the lengths and types of chemical bonds and the size of atoms.
Technavio’s analysts forecast the Global X-ray Crystallography Market to grow at a CAGR of 10.51% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the x-ray crystallography market. To calculate the market size, the report considers the revenue generated from the retail sales of X-ray crystallography instruments and services in the Americas, EMEA, and APAC.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, x-ray crystallography market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bruker
• Charles River
• PerkinElmer
• Rigaku
• Shimadzu
• Thermo Fisher Scientific
Market driver
• Growing investment on drug discovery
• For a full, detailed list, view our report
Market challenge
• Lack of trained laboratory professionals
• For a full, detailed list, view our report
Market trend
• Outsourcing of drug discovery process
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Comparison by end-user
• Pharmaceutical industry – Market size and forecast 2017-2022
• Biotechnology sector – Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Outsourcing of drug discovery process
• Increasing demand for portable instruments
• Global initiatives encouraging proteomics research
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bruker
• Charles River
• PerkinElmer
• Rigaku
• Shimadzu
• Thermo Fisher Scientific
PART 15: APPENDIX
• List of abbreviations
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global X-ray crystallography market – Market size and forecast 2017-2022 ($ mn)
Exhibit 08: Global X-ray crystallography market – Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Customer landscape
Exhibit 18: Global X-ray crystallography market by end-user – Market share 2017-2022 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Global X-ray crystallography market by pharmaceutical industry – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global X-ray crystallography market by pharmaceutical industry – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global X-ray crystallography market by biotechnology sector – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global X-ray crystallography market by biotechnology sector – Year-over-year growth 2018-2022 (%)
Exhibit 24: Global X-ray crystallography market by others – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Global X-ray crystallography market by others – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Global X-ray crystallography market by region – Market share 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: X-ray crystallography market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: X-ray crystallography market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: X-ray crystallography market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: X-ray crystallography market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: X-ray crystallography market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: X-ray crystallography market in APAC – Year-over-year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Market opportunity
Exhibit 39: Average percentage of GDP spent by OECD countries on R&D
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Bruker overview
Exhibit 46: Bruker – Business segments
Exhibit 47: Bruker – Organizational developments
Exhibit 48: Bruker – Geographic focus
Exhibit 49: Bruker – Segment focus
Exhibit 50: Bruker – Key offerings
Exhibit 51: Charles River overview
Exhibit 52: Charles River – Business segments
Exhibit 53: Charles River – Organizational developments
Exhibit 54: Charles River – Geographic focus
Exhibit 55: Charles River – Segment focus
Exhibit 56: Charles River – Key offerings
Exhibit 57: PerkinElmer overview
Exhibit 58: PerkinElmer – Business segments
Exhibit 59: PerkinElmer – Organizational developments
Exhibit 60: PerkinElmer – Geographic focus
Exhibit 61: PerkinElmer – Segment focus
Exhibit 62: PerkinElmer – Key offerings
Exhibit 63: Rigaku overview
Exhibit 64: Rigaku – Business segments
Exhibit 65: Rigaku – Organizational developments
Exhibit 66: Rigaku – Key offerings
Exhibit 67: Shimadzu overview
Exhibit 68: Shimadzu – Business segments
Exhibit 69: Shimadzu – Organizational developments
Exhibit 70: Shimadzu – Geographic focus
Exhibit 71: Shimadzu – Segment focus
Exhibit 72: Shimadzu – Key offerings
Exhibit 73: Thermo Fisher Scientific overview
Exhibit 74: Thermo Fisher Scientific – Business segments
Exhibit 75: Thermo Fisher Scientific – Organizational developments
Exhibit 76: Thermo Fisher Scientific – Geographic focus
Exhibit 77: Thermo Fisher Scientific – Segment focus
Exhibit 78: Thermo Fisher Scientific – Key offerings
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Comparison by end-user
• Pharmaceutical industry – Market size and forecast 2017-2022
• Biotechnology sector – Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Outsourcing of drug discovery process
• Increasing demand for portable instruments
• Global initiatives encouraging proteomics research
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bruker
• Charles River
• PerkinElmer
• Rigaku
• Shimadzu
• Thermo Fisher Scientific
PART 15: APPENDIX
• List of abbreviations
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global X-ray crystallography market – Market size and forecast 2017-2022 ($ mn)
Exhibit 08: Global X-ray crystallography market – Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Customer landscape
Exhibit 18: Global X-ray crystallography market by end-user – Market share 2017-2022 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Global X-ray crystallography market by pharmaceutical industry – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global X-ray crystallography market by pharmaceutical industry – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global X-ray crystallography market by biotechnology sector – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global X-ray crystallography market by biotechnology sector – Year-over-year growth 2018-2022 (%)
Exhibit 24: Global X-ray crystallography market by others – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Global X-ray crystallography market by others – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Global X-ray crystallography market by region – Market share 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: X-ray crystallography market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: X-ray crystallography market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: X-ray crystallography market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: X-ray crystallography market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: X-ray crystallography market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: X-ray crystallography market in APAC – Year-over-year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Market opportunity
Exhibit 39: Average percentage of GDP spent by OECD countries on R&D
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Bruker overview
Exhibit 46: Bruker – Business segments
Exhibit 47: Bruker – Organizational developments
Exhibit 48: Bruker – Geographic focus
Exhibit 49: Bruker – Segment focus
Exhibit 50: Bruker – Key offerings
Exhibit 51: Charles River overview
Exhibit 52: Charles River – Business segments
Exhibit 53: Charles River – Organizational developments
Exhibit 54: Charles River – Geographic focus
Exhibit 55: Charles River – Segment focus
Exhibit 56: Charles River – Key offerings
Exhibit 57: PerkinElmer overview
Exhibit 58: PerkinElmer – Business segments
Exhibit 59: PerkinElmer – Organizational developments
Exhibit 60: PerkinElmer – Geographic focus
Exhibit 61: PerkinElmer – Segment focus
Exhibit 62: PerkinElmer – Key offerings
Exhibit 63: Rigaku overview
Exhibit 64: Rigaku – Business segments
Exhibit 65: Rigaku – Organizational developments
Exhibit 66: Rigaku – Key offerings
Exhibit 67: Shimadzu overview
Exhibit 68: Shimadzu – Business segments
Exhibit 69: Shimadzu – Organizational developments
Exhibit 70: Shimadzu – Geographic focus
Exhibit 71: Shimadzu – Segment focus
Exhibit 72: Shimadzu – Key offerings
Exhibit 73: Thermo Fisher Scientific overview
Exhibit 74: Thermo Fisher Scientific – Business segments
Exhibit 75: Thermo Fisher Scientific – Organizational developments
Exhibit 76: Thermo Fisher Scientific – Geographic focus
Exhibit 77: Thermo Fisher Scientific – Segment focus
Exhibit 78: Thermo Fisher Scientific – Key offerings
